Health professionals working in feeding/swallowing clinics frequently recommend the use of thickening agents for therapeutic purposes with both adult and pediatric caseloads. Within the pediatric population, thickened fluids are often recommended by health professionals for two main groups of patients: (1) children at risk of aspirating regular (i.e., thin) fluids into their airway, and (2) those children who display regurgitation. The rationale behind thickening fluids is to assist with the safe swallowing of fluids and/or to reduce the regurgitation of feeds, thereby optimising nutritional status and, it is assumed, preventing dehydration. However, little information is currently available regarding the bioavailability of water from thickened fluids.

The issue of hydration is of particular importance when managing pediatric patients. Fluid, in the form of infant formula or breast milk, is an infant's sole source of nutrition until approximately 6 months, and a large part of their diet until approximately 12 months. Therefore, any reduction in the availability of water from fluid feeds could not be compensated for by water from solid food types. In addition, due to the nature of their disorder, patients with dysphagia and/or regurgitation may have more difficulty consuming their daily fluid intake requirements than the general population \[[@CR1]\]. Any irreversible binding of water by thickening agents would have the potential to exacerbate this problem by limiting the water available from any fluid that is consumed. This would have the potential to lead to dehydration and associated problems. Furthermore, poor fluid availability may have the potential to make any feeding problems in this population worse, as constipation, a common symptom of dehydration, may result in reduced hunger, irritability and behavioral issues \[[@CR2]\].

Sharpe et al. \[[@CR3]\] recently produced the first (and, to our knowledge, only) published research on the issue of bioavailability of water from thickened fluids. Sharpe et al. \[[@CR3]\] developed a novel method for testing the bioavailability of water from thickened fluids. Specifically, the investigators provided participants with repeated test samples of water containing bromide and deuterium oxide (^2^H~2~O) mixed with various thickening agents (namely, modified maize starch, guar gum, and xanthan gum) for consumption. Participants were required to give a 5-ml blood sample before being dosed with each test fluid and at 240 min postdosing. In addition, saliva samples were taken before dosing and at 10, 20, 30, 45, 60, 90, 120, and 240 min postdosing. The investigators also tested participants' bioelectrical impedance pre- and postconsumption of thickened fluids. They concluded that the addition of certain commonly used thickening agents did not significantly alter the absorption rate of water from the healthy, mature human gut.

This article is a "proof of concept" study that details a simple method for assessing the bioavailability of water when mixed with fluid thickeners that is more accurate and less invasive than that proposed by Sharpe et al. \[[@CR3]\]. For the purpose of illustrating our method, we have used a fluid thickened with xanthan gum and administered to a single subject as a case study.

Methods {#Sec2}
=======

Procedure {#Sec3}
---------

Total body water (TBW) was measured on two consecutive days using stable, nonradioactive, nontoxic isotopes. For the first measurement of TBW, the participant was given an oral dose of an isotope of oxygen (O^18^), in the form of water (H~2~^18^O). The subject consumed 1.5 g/kg body weight of 4% H~2~^18^O via a syringe to minimise residue. The dose consumed was recorded to the nearest 10 mg. A single urine sample was obtained before the dose and subsequent urine samples were collected 4--6 h postdose and then once every 24 h (approximately) for the following 15 days. The subject recorded the time each urine sample was collected.

At the same time the following day, TBW was again measured using an isotope of hydrogen (^2^H) in the form of water (^2^H~2~O, deuterium oxide). The subject consumed via a syringe 0.05 g/kg body weight of 99.9% deuterium oxide mixed into a sample of 50 ml tap water plus a xanthan gum fluid thickener (EasyThick, Flavour Creations). Xanthan gum was chosen for the purpose of illustrating our novel stable isotope method because it is a commonly used fluid thickener, and it was one of thickening agents tested by Sharpe et al. \[[@CR3]\]. Other thickening agents may be substituted for labeling with ^2^H, and the ^2^H could be added to sample fluids other than tap water (e.g., juice, cordial, milk, infant formula). The solution was thickened according to the manufacturer's instructions to produce a solution thickened to full (pudding) thick. The dose was recorded to the nearest 10 mg. A single urine sample was obtained before the dose and 4--6 h postdose. The daily urine samples collected for ^18^O analysis were also used for ^2^H analysis. All urine samples were frozen until analysis. It was not necessary to place predose restrictions on the participant with respect to food or drink consumption on either of the testing days, as this method yields an average result from the collection of multiple urine samples over a 2-week period. In addition, the isotopic enrichment of each postdose sample is analysed with respect to the predose urine sample; this effectively serves as a control. Therefore, unlike methods that measure the rate of appearance of isotopes in bodily fluid, this method is not affected by short-term differences in gastric emptying or intestinal absorption rates in relation to prior food or beverage consumption.

To determine each dilution space and measure TBW, the enrichment of ^2^H and ^18^O in the predose and postdose urine samples, the dose administered, and the local tap water were assessed via isotope ratio mass spectrometry (IRMS) (PDZ Europa, UK).

To measure the enrichment of ^2^H, 0.5 ml of each urine sample was pipetted into a 12-ml vacuutainer. A catalyst, approximately 1 mg of platinum on alumina powder (Sigma Aldrich) contained in a 0.5-ml vial (Hewlett Packard Pty), was introduced into the vacuutainer while ensuring no direct contact of the catalyst and the urine. Each vacuutainer was evacuated for a period of 5 min before being filled with 99% hydrogen gas. The vaccutainers were then kept at room temperature for 3 days to allow the ^2^H in the sample to achieve equilibrium with the hydrogen gas \[[@CR4]\]. All reference waters were prepared at the same time and in the same manner as the urine samples.

Similarly, to measure the enrichment of ^18^O, 0.5 ml of each urine sample were pipetted into a 12-ml vacuutainer. The vacuutainers were then evacuated for 5 minutes, and 5% carbon dioxide, 95% nitrogen gas was introduced into the vacuutainer. The samples were then kept at room temperature for 24 h to facilitate the equilibrium between the ^18^O in the sample and the gas. Again, reference waters were prepared at the same time and in the same manner as the urine samples.

The enrichment of both the ^2^H and ^18^O samples were measured in duplicate with the results being expressed in delta units as ‰ (per mil) relative to standard mean ocean water (SMOW).

The theoretical instantaneous enrichments of body water, which could be obtained by the administered dose and defined as the intercept obtained by back-extrapolation of the semilogarithmic plot of observed enrichment against time, is given by a rearrangement of the equation of Halliday and Miller \[[@CR5]\] as$$\documentclass[12pt]{minimal}
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Participant {#Sec4}
-----------

A single participant (PMMD) volunteered for the purposes of testing. Informed consent was obtained from the participant.

Results {#Sec5}
=======

The age of the subject was 25 years, height 181 cm, and weight 64 kg. The complete set of isotope data recorded for this subject is given in Table [1](#Tab1){ref-type="table"}. The estimated oxygen distribution space was 523 mg/kg, yielding an estimated TBW of 518 ml/kg, which is in the well-documented physiologic range. The bioavailability of water from the thickened fluid was 0.97 ± 0.06 (mean ± standard error), suggesting that the xanthan gum fluid thickener was not binding the deuterium \[i.e., water (^2^H~2~O)\] with which it was mixed, and, therefore, the bioavailability of the water in the solution was unaffected by the addition of the thickening agent.Table 1Subject isotopic enrichment data and calculated total body water and bioavailability of water from the thickened fluid (±standard error as percentage)*E*~D~*E*~aD~ − *E*~tD~*E*~O~*E*~aO~ − *E*~tO~TBW (L) from ^18^O*F*~D~520.8 ± 2.1%1028 ± 1.3%64.0 ± 1.5%32.8 ± 1.3%33.66 ± 2.8%0.97 ± 6.4%

Discussion {#Sec6}
==========

Sharpe et al. \[[@CR3]\] described a method to determine the influence of thickening agents on the absorption of water. Our short report is a "proof of concept" study aimed at detailing a more accurate, less invasive approach to that proposed by Sharpe et al. \[[@CR3]\], involving isotopically labeling a thickened fluid to assess the bioavailability of water when mixed with a thickening agent.

The approach discussed by Sharpe et al. \[[@CR3]\] involved assessing water absorption by labeling a thickened fluid with ^2^H and measuring the rate of appearance of ^2^H in saliva and blood samples. In addition, the thickened fluid was also labeled with sodium bromide to determine the extracellular water space, and bioelectrical impedance (BIA) was used to measure TBW. While (similar to our methods) this method involves the oral ingestion of a labeled thickened fluid and, thus, allows assessment in a physiologically "real" environment, it is nevertheless associated with several problems. First, it is difficult to ensure that residual amounts of the isotopic tracer labeling an orally ingested fluid do not remain in the mouth and, therefore, alter the enrichment of saliva samples. While attempts were made by the authors to minimise this potential source of error, saliva samples are less than ideal in these circumstances, unless alternative methods are used to label the fluid \[[@CR7]\]. Second, this method looks at the rate of appearance of ^2^H over a short time and, thus, is more susceptible to the confounding effects of diuretics and pretest food consumption, particularly with respect to gastric emptying and intestinal absorption rates. Third, while BIA is an inexpensive, noninvasive, and reliable method of measuring TBW, it is not always accurate \[[@CR8]\], especially in comparison to the isotope techniques utilised in our methodology. In addition, Sharpe et al. also collected blood samples for comparison with the results of the saliva samples. This sample collection method is limited as it is an invasive procedure that is not well tolerated by some individuals. Finally, adding sodium bromide to an orally ingested fluid may not be palatable because it has a strong salty taste and thus its use may be limited in certain populations, such as children.

We, therefore, believe our methodology to be more accurate and less invasive than that of Sharpe et al. \[[@CR3]\]. ^2^H and ^18^O are stable, nonradioactive, nontoxic isotopes of hydrogen and oxygen, respectively. They are ingested in the form of water (^2^H~2~O and H~2~^18^O) and, therefore, taste similar to ordinary tap water. Samples are collected via urine and, therefore, there are no contamination issues related to residual amounts of tracer remaining in the oral cavity, as with saliva samples. Urine samples are easily collected from subjects of any age (from preterm infants to the elderly) and, when required, may be collected via cotton balls placed in a diaper; catheterisation is not necessary due to the small volumes of urine needed (approximately 2 ml). Urine samples are easy to work with for analysis and our method is noninvasive for the subject. Finally, stable isotope techniques are associated with good accuracy and precision \[[@CR9]\] and are considered the gold standard for the measurement of TBW.

However, a limitation of our method is the relative expense of the ^18^O isotope. At the time of publication, it would cost approximately 105 \$US to dose a 60-kg adult with the amount of ^18^O used in our study. While improvements in isotope ratio mass spectrometry allow smaller and smaller dosages to be used, it is still a relatively expensive way to measure TBW, compared with either ^2^H or other techniques like BIA. However, while relatively expensive, the accuracy of isotope labeling is a major benefit of this technique.

The results presented here indicate that the thickening agent tested does not alter the apparent bioavailability of water. Obviously, our single-subject, single-thickened-fluid example was used to describe the novel method we propose rather than prove the effect of this thickening agent on the bioavailability of water per se. There are many thickening agents available on the market for patient use, and we believe that it is important that they are all tested to determine their impact on the bioavailability of the water in fluids with which they are mixed. Specifically, it cannot be assumed that different thickening agents will interact in the same way with a fluid, or indeed that the same thickening agent will interact in the same way with different fluids (e.g., water-based fluids vs. nutrient-dense milk-based fluids) \[[@CR10]\]. Therefore, it is essential that different combinations of fluids and thickening agents offered to patients are tested to determine the bioavailability of water from different thickened fluids. We recommend our methodology as being both an accurate and minimally invasive way to do so.

A further question that needs to be investigated is whether certain individuals may be more or less effective at digesting thickening agents and, thus, altering the availability of water from thickened fluids. Interestingly, Sharpe et al. \[[@CR3]\] reported intersubject variation in the rate of water uptake in their healthy, nonclinical sample group, which may be indicative of this phenomenon. Further research with greater numbers of participants is needed to investigate this possibility. In particular, attention needs to be given to the effect of gut pathology and/or the interference of medication such as histamine-2 receptor antagonists and proton pump inhibitors, on the digestion of various thickening agents. This is especially so, given that many patients are initiated on thickening agents in an attempt to manage the symptoms of regurgitation and, therefore, will almost certainly have some degree of gut pathology and/or be exposed to acid suppression medications. Many dysphagic patients who use thickened fluids as a way to minimise aspiration during swallowing may also have a coinciding gut pathology \[[@CR11]\].

This study detailed a novel method for investigating the bioavailability of water when mixed with thickening agents. Another separate but equally important issue that merits further investigation is the bioavailability of nutrients from thickened fluids. Several in vitro studies have suggested that a variable proportion of certain micronutrients can become irreversibly bound to some types of thickening agents and, thus, be rendered unavailable for digestion \[[@CR12]--[@CR14]\]. Clearly, if confirmed, this would have implications for the use of certain thickening agents with nutrition-providing liquids (e.g., infant formula, nutritional supplement drinks). However, if the proportional bioavailability of nutrients could be calculated, additional volumes of the nutrients could be provided to allow for some irreversible binding to the thickening agent.

Conclusion {#Sec7}
==========

This "proof of concept" study describes a novel approach for determining the bioavailability of the water from thickened fluids, involving the measurement of the dilution space ratios of the isotopes ^2^H and ^18^O. Using xanthan gum as the thickening agent and a single subject, we have shown that our method is simple, noninvasive, and accurate. We recommend that further testing is required with larger participant numbers, other thickening agents, and a variety of fluids with which thickeners are commonly mixed. We believe that it is important that all thickening agents recommended for patient use be tested to determine their impact on the bioavailability of the water in the fluids with which they are mixed and recommend our methodology as currently being the most accurate and least invasive.
